User:Mr. Ibrahem/Tivozanib

Tivozanib, sold under the brand name Fotivda, is a medication used to treat renal cell carcinoma (RCC). Specifically it is used for advanced disease which has failed other treatments. It is taken by mouth.

Common side effects include tiredness, high blood pressure, diarrhea, nausea, change in voice, low thyroid, cough, and mouth inflammation. Other side effects may include low sodium, heart problems, blood clots, bleeding, and increased lipase. Use in pregnancy may harm the baby. It is a VEGF receptor tyrosine kinase inhibitor, which blocks the formation of new blood vessels.

Tivozanib was approved for medical use in Europe in 2017 and the United States in 2021. In the United States 4 weeks of treatment costs about 26,000 USD.